Home/Filings/4/0001437749-13-015111
4//SEC Filing

RESPONSE BIOMEDICAL CORP 4

Accession 0001437749-13-015111

CIK 0000806888operating

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 2:40 PM ET

Size

5.1 KB

Accession

0001437749-13-015111

Insider Transaction Report

Form 4
Period: 2013-11-20
Wang David
Director
Transactions
  • Award

    Restricted Share Units

    2013-11-20+5,9255,925 total
    Common Stock (5,925 underlying)
Footnotes (2)
  • [F1]Each restricted share unit represents a contingent right to receive one share of the company's common stock.
  • [F2]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the later of three (3) years after the effective date or two (2) years following the grantee's termination date.

Issuer

RESPONSE BIOMEDICAL CORP

CIK 0000806888

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0000806888

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 2:40 PM ET
Size
5.1 KB